Anteris Technologies Global Corp. Common Stock (AVR)vsBecton Dickinson and Company (BDX)
AVR
Anteris Technologies Global Corp. Common Stock
$5.39
-1.46%
HEALTHCARE · Cap: $544.50M
BDX
Becton Dickinson and Company
$158.27
+1.51%
HEALTHCARE · Cap: $56.49B
Smart Verdict
WallStSmart Research — data-driven comparison
Becton Dickinson and Company generates 1145953% more annual revenue ($21.92B vs $1.91M). BDX leads profitability with a 8.0% profit margin vs 0.0%. BDX earns a higher WallStSmart Score of 61/100 (C+).
AVR
Avoid17
out of 100
Grade: F
BDX
Buy61
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AVR.
Margin of Safety
+36.9%
Fair Value
$286.42
Current Price
$158.27
$128.15 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Large-cap with strong market position
Reasonable price relative to book value
Earnings expanding 28.6% YoY
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -3.0% — below average capital efficiency
Moderate valuation
1.6% revenue growth
ROE of 7.0% — below average capital efficiency
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AVR
AVR has a balanced fundamental profile.
Bull Case : BDX
The strongest argument for BDX centers on Market Cap, Price/Book, EPS Growth. PEG of 1.16 suggests the stock is reasonably priced for its growth.
Bear Case : AVR
The primary concerns for AVR are EPS Growth, Market Cap, Profit Margin.
Bear Case : BDX
The primary concerns for BDX are P/E Ratio, Revenue Growth, Return on Equity.
Key Dynamics to Monitor
AVR carries more volatility with a beta of 0.42 — expect wider price swings.
BDX is growing revenue faster at 1.6% — sustainability is the question.
BDX generates stronger free cash flow (549M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BDX scores higher overall (61/100 vs 17/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Anteris Technologies Global Corp. Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Anteris Technologies Global Corp. The company is headquartered in Toowong, Australia.
Becton Dickinson and Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?